Posted on 9/19/16
McKesson Health Solutions Introduces the Intelligence Hub
NEWTON, Mass.--(BUSINESS WIRE)--Today McKesson Health Solutions (MHS) unveiled the McKesson Intelligence Hub™, a new technology platform for enabling interoperability and sharing business intelligence among healthcare applications. . . .
Posted on 9/19/16
FierceBiotech Names C4 Therapeutics as One of Its “Fierce 15” Biotech Companies of 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--C4 Therapeutics (C4T) today announced that it has been named byFierceBiotech as one of 2016’s Fierce 15 biotechnology companies, designating it as one of . . .
Posted on 9/19/16
Tufts Health Freedom Plan and Northeast Delta Dental Partner to Improve Oral, Overall Health
CONCORD, N.H.--(BUSINESS WIRE)--Recognizing that oral and overall health are linked, Tufts Health Freedom Plan and Northeast Delta Dental today announced a new partnership with the goal . . .
Posted on 9/16/16
Why CoLucid Pharmaceuticals Inc. Soared As Much As 18% on Thursday
IMAGE SOURCE: GETTY IMAGES.What happenedShares of CoLucid Pharmaceuticals (NASDAQ:CLCD), a small-cap clinical-stage biopharmaceutical company focused on the development small-molecule drugs for the treatment of migraines, surged . . .
Posted on 9/16/16
Courtagen Life Sciences Collaborates with Astellas Pharma
WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., a molecular information company that brings comprehensive neurological genome analysis to routine clinical care, announced a collaboration with Astellas Pharma . . .
Posted on 9/15/16
Does This News Make Sarepta Therapeutics a Buy?
IMAGE SOURCE: STOCKMONKEYS.COM VIA FLICKR.Short sellers have been betting against an FDA approval of Sarepta Therapeutics'(NASDAQ:SRPT) Duchenne muscular dystrophy (DMD) drug, eteplirsen, and I can't say . . .
Posted on 9/15/16
Agios Announces Pricing of $150 Million Public Offering of Common Stock
CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO) today announced that it has priced an underwritten public offering of 3,370,786 shares of . . .
Posted on 9/14/16
IMS Health Prices Notes Offering
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (NYSE:IMS) today announced the pricing of its offering of $1.75 billion equivalent in gross proceeds . . .
Posted on 9/14/16
Proteostasis Therapeutics Closes Follow-On Public Offering of Common Stock
CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein . . .
Posted on 9/14/16
Dr. Patrick Hwu Joins Dragonfly Therapeutics' Scientific Advisory Board
Dragonfly Therapeutics, Inc. announced the addition of one of the leading tumor immunologists in the country,
Posted on 9/14/16
Optum and Quest Diagnostics Partner
WAKEFIELD, Mass. & MADISON, N.J.--(BUSINESS WIRE)--Optum, a leading information and technology-enabled health services business, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, . . .
Posted on 9/13/16
Andrew Braziel, MD Joins New England Baptist Hospital
Orthopedic surgeon Andrew Braziel, MD has joined New England Baptist Hospital, a Boston-based premier regional
Posted on 9/13/16
Acetylon Pharmaceuticals Renews In The Seaport
CBRE/New England announced that Acetylon Pharmaceuticals, the leader in the development of selective histone
Posted on 9/14/16
Dr. Robert Leonard Presents at the 6th Annual Congress of the Brazilian Association for Hair Restoration Surgery
Dr. Robert Leonard, chief surgeon and founder of Leonard Hair Transplant Associates, recently presented at the 6th Annual Congress of the Brazilian Association for Hair Restoration . . .
Posted on 9/13/16
IMS Health Announces Notes Offering
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly owned subsidiary, IMS Health Incorporated, intends to raise $1.5 . . .
Posted on 9/13/16
Advantagene Closes $14.2 Million in Private Placement Financing
Advantagene, Inc., a clinical stage biotechnology company focused on immuno-oncology products, announced today that it has closed on a private placement of its Series A Convertible . . .
Posted on 9/13/16
Semma Therapeutics Announces $5 Million Grant from California Institute of Regenerative Medicine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Semma Therapeutics, a biopharmaceutical company developing cellular therapy for diabetes, announced today that it has accepted a $5 million grant from the California Institute . . .
Posted on 9/12/16
3 All-or-Nothing Biotechs I'm Watching Like a Hawk
IMAGE SOURCE: GETTY IMAGES.Every small-cap biotech stock whose future depends on the success of a single compound will eventually face a binary event. Whether that event . . .
Posted on 9/12/16
3 Stocks to Avoid in the Biotechnology Sector
IMAGE SOURCE: GETTY IMAGES.Perhaps more than any other industry, biotechnology start-ups face long, treacherous paths to profitability, and a majority never make it. If you think . . .
Posted on 9/9/16
This Crushing Blow Sent Bristol-Myers Squibb Co. Down 23% in August
IMAGE SOURCE: GETTY IMAGES.What happenedShares of Bristol-Myers Squibb (NYSE:BMY), a global drug developer focused on the development cancer, cardiovascular, and genetic-defined disease drugs, plunged 23% in . . .
Posted on 9/9/16
Better Buy: Biogen Inc. vs. Gilead Sciences
IMAGE SOURCE: GETTY IMAGES.A closer look at Biogen's (NASDAQ:BIIB) most exciting asset recently caught the attention of the wider public, while Gilead Sciences' (NASDAQ:GILD) hepatitis C . . .
Posted on 9/9/16
Tokai Pharmaceuticals Announces Review of Strategic Alternatives
BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced . . .
Posted on 9/9/16
Sage Therapeutics Prices Stock Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the pricing of . . .
Posted on 9/8/16
Insulet Prices Senior Notes
BILLERICA, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today . . .
Posted on 9/8/16
Proclara Biosciences Raises $47 Million Series E
Proclara Biosciences, a biotechnology company developing novel therapies for diseases caused by protein misfolding, today announced that
Boston
